Sagent Pharmaceuticals (SGNT) Announces First Quarter 2011 Financial Results Teleconference and Webcast

SCHAUMBURG, Ill., May 5, 2011 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will host a teleconference and webcast to provide a general business overview and discuss first quarter 2011 financial results on Friday, May 13, 2011 at 10 a.m. ET. Financial results for first quarter ended March 31, 2011 will be released earlier that day.

Interested parties may access a live webcast of the presentation on the company’s website at: http://investor.sagentpharma.com/events.cfm.

Within the United States:	877-293-5456
International:	707-287-9357

A replay of the presentation will be available on the Sagent website or by dialing:

Toll-Free:	800-642-1687
Passcode:	65115990

The replay will be available until May 27, 2011.

About Sagent Pharmaceuticals

Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.

CONTACT: Sagent Contact:
         Ron Pauli
         (847) 908-1604

         Media Contact:
         Geoff Curtis, WCG
         (312) 646-6298